LALPATHLAB Quarterly Results, Profit & Loss, Balance Sheet (LALPATHLAB)

LALPATHLAB quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

Dr. Lal PathLabs Ltd (LALPATHLAB) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Dr. Lal PathLabs Ltd reported sales of ₹874 Cr, operating profit of ₹280 Cr (OPM 32%) and net profit of ₹194 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

LALPATHLAB quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales597603670731660703798874
YoY Sales growth1110111111171920
Expenses443434478506480516550594
Operating Profit154169192224179187248280
OPM26%28%29%31%27%27%31%32%
Other Income25262825-6243234
Interest55557667
Depreciation3636354042454447
Profit before tax138153181204124160229260
Tax29%-1%26%25%26%17%25%26%
Net Profit9815613415291132170194
EPS in Rs5.789.267.98.995.47.8410.1111.55
LALPATHLAB profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,0872,0172,2272,4612,7633,034
Sales growth32-310111217
Expenses1,5261,5271,6171,7641,9792,140
Operating Profit561490609698783894
OPM27%24%27%28%28%29%
Other Income524269917084
Interest303829222327
Depreciation108150144142162178
Profit before tax475344505625669774
Tax26%30%28%21%24%-
Net Profit350241362492510588
EPS in Rs20.6914.3321.4229.1430.1334.9
Dividend Payout29%42%0%41%68%-
LALPATHLAB balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital838484168168
Reserves1,7662,0892,3042,3412,577
Borrowings247157156199233
Other Liabilities357383415433480
Total Liabilities2,4542,7132,9593,1403,458
Fixed Assets1,2281,1681,2321,2561,310
CWIP631775
Investments114327486423530
Other Assets1,1071,2151,2251,4541,612
Total Assets2,4542,7132,9593,1403,458
LALPATHLAB cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity447456535569636
Cash from Investing Activity-449-287-24-303-422
Cash from Financing Activity136-283-414-334-264
Net Cash Flow134-11497-68-50
Free Cash Flow-28412479516463
CFO/OP103%115%110%105%104%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit103115110105104
LALPATHLAB ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1513131315
Inventory Days3828302730
Days Payable107127151127123
Cash Conversion Cycle-54-87-108-86-79
Working Capital Days-54-56-46-30-29
ROCE29%18%25%29%28%